Schlemm's canal-selective Tie2/TEK knockdown induces sustained ocular hypertension in adult mice

• Published in: Experimental eye research 2024-11, Vol.248, p.110114, Article 110114
• Main Authors: Schwakopf, Joon, Romero, Cesar O., Lopez, Navita N., Millar, J. Cameron, Vetter, Monica L., Bosco, Alejandra
• Format: Article
• Language: English
• Subjects: AAV2; Animals; Aqueous Humor - metabolism; CRISPR/SaCas9; Dependovirus - genetics; Disease Models, Animal; Gene Knockdown Techniques; Genetic Vectors; Glaucoma; Intraocular pressure; Intraocular Pressure - physiology; Limbus Corneae - metabolism; Mice; Mice, Inbred C57BL; Mice, Knockout; Ocular Hypertension - genetics; Ocular Hypertension - metabolism; Receptor, TIE-2 - genetics; Receptor, TIE-2 - metabolism; Schlemm's Canal; Tie2/TEK; Trabecular meshwork; Trabecular Meshwork - metabolism
• ISSN: 0014-4835; 1096-0007; 1096-0007
• DOI: 10.1016/j.exer.2024.110114

Deficient Angiopoietin-Tie2 signaling is linked to ocular hypertension in glaucoma. Receptor Tie2/TEK expression and signaling at Schlemm's canal (SC) is indispensable for canal integrity and homeostatic regulation of aqueous humor outflow (AHO) and intraocular pressure (IOP), as validated by conditional deletion of Tie2, its ligands (Angpt1, Angpt2 and Angpt3/4) or regulators (Tie1 and PTPRB/VE-PTP). However, these Tie2/TEK knockouts and conditional knockouts are global or endothelial, preventing separation of systemic and ocular vascular defects that impact retinal or renal integrity. To develop a more targeted model of ocular hypertension induced by selective knockdown of Tie2/TEK expressed in SC, we combined the use of viral vectors to target the canal, and two distinct gene-editing strategies to disrupt the Tie2 gene. Adeno-associated virus (AAV2) is known to transduce rodent SC when delivered into the anterior chamber by intracameral injection. First, delivery of Cre recombinase via AAV2.Cre into R26tdTomato/+ reporter mice confirmed preferential and stable transduction in SC endothelium. Next, to disrupt Tie2 expression in SC, we injected AAV2.Cre into homozygous floxed Tie2 (Tie2FL/FL) mice. This led to attenuated Tie2 protein expression along the SC inner wall, decreased SC area and reduced trabecular meshwork (TM) cellularity. Functionally, IOP was significantly and steadily elevated, whereas AHO facility was reduced. In contrast, hemizygous Tie2FL/+ mice responded to AAV2.Cre with inconsistent and low IOP elevation, corroborating the dose-dependency of ocular hypertension on Tie2 expression/activation. In a second model using CRISPR/SaCas9 genome editing, wild-type C57BL/6 J mice injected with AAV2.saCas9-sgTie2 showed similar selective SC transduction and comparable IOP elevation in course and magnitude to that induced by AAV2.Cre in Tie2FL/FL mice. Together, our findings, demonstrate that selective Tie2 knockdown in SC is a targeted strategy that reliably induces chronic ocular hypertension and reproduces glaucomatous damage to the conventional outflow pathway, providing novel models of SC-Tie2 signaling loss valuable for preclinical studies. [Display omitted] •Intracameral AAV2 stably transduces Cre recombinase or SaCas9 in Schlemm's canal (SC).•AAV2-Cre in Tie2FL/FL mice selectively attenuates Tie2 expressed in SC-inner wall endothelium.•Structurally, SC area reduces and the contiguous trabecular meshwork (TM) regresses.•Functionally, steady